In line with increased PDGF-CC expression in various tumours analysed in our study, it has been previously shown that PDGF-CC upregulation correlates with poorer prognosis of breast cancer, [46] colorectal cancer, [47] and glioma [48]. This evidence concerns the gene CXCR1 and colorectal cancer.